in the latest sign of how automation and the increasing use of artificial intelligence are having a negative impact on the tech labor market. The number of unemployed IT workers rose from ...
Wall Street took a big hit on Monday morning, with a number of major tech and media stocks dropping on the first day of trading after President Donald Trump imposed stiff tariffs on Mexican ...
SINGAPORE—Chinese officials are building a list of U.S. technology companies that can be targeted with antitrust probes and other tools, hoping to influence the tech executives who are heavily ...
The Tech Adoption Index is part of Tech Mahindra's ongoing collaboration with The Wall Street Journal to explore key factors for deploying digital infrastructure. The report will be available as a ...
Wee Charlie is clearly the one to beat in the 14:00 at Thurles as he switches from hurdles to fences and from a mark of 104 could be chucked in, but 15/82.88 in a field of 13 pushes me towards an ...
Invest in JPMorgan U.S. Tech Leaders ETF (JTEK) for high-growth tech stocks, but wait for a pullback for better entrance ...
In case of abuse, Report this post. Israelis are facing a serious threat from an unhinged international court, and J Street is rushing to the court’s defense. The International Criminal Court ...
STORY: U.S. stocks ended lower on Thursday as investors parsed the latest corporate earnings and economic data, and Big Tech stocks weighed on the Nasdaq. The Dow and S&P 500 both dipped slightly ...
NEW YORK — Calm is returning to Wall Street Tuesday, and tech stocks are leading U.S. stock indexes higher following a strong profit report from Palantir Technologies, a darling benefitting from ...
TUS Dr Harty Cup final: Thurles CBS 1-13 St Flannan’s College, Ennis 0-13 Thurles CBS captain Robbie Ryan lifts the trophy after winning the Dr Harty Cup final. Photo: John Sheridan/Sportsfile ...
Good ground at Thurles on Sunday will be slightly problematic for a few, and with doubts elsewhere about the unseasonable going for the 14:35 2m6f Handicap Chase, the favourite That's About Right ...
Spravato was already available in the market before today's FDA approval and has already proven to be a financial success for J&J but only as an adjunct therapy to oral antidepressants for TRD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results